Regeneron Pharmaceuticals Price Prediction and Hype Density Breakdown

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:4em;padding-top: 15px;;'>RE</div>
REGN -- USA Stock  

Earning Report: February 6, 2020  

We analyze noise-free headlines and recent hype associated with Regeneron Pharmaceuticals which may create opportunities for some arbitrage if properly timed. With Regeneron Pharmaceuticals hype-based prediction module you can estimate the value of Regeneron Pharmaceuticals from the prospective of Regeneron Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Regeneron Pharmaceuticals over a specific investment horizon. Additionally take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
Horizon     30 Days    Login   to change

Regeneron Pharmaceuticals After-Hype Price Density Analysis

 Next price density 
  Expected price to next headline 

Regeneron Pharmaceuticals Estimiated After-Hype Price Volatility

Current Value
January 23, 2020
After-hype Price
Regeneron Pharmaceuticals is very steady asset. Analysis and calculation of next after-hype price of Regeneron Pharmaceuticals is based on 3 months time horizon.

Regeneron Pharmaceuticals Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.26  1.86  0.91   0.24  8 Events / Month3 Events / MonthIn about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Regeneron Pharmaceuticals Hype Timeline

Regeneron Pharmaceuticals is at this time traded for356.60. The entity has historical hype elasticity of 0.91 and average elasticity to hype of competition of 0.24. Regeneron Pharmaceuticals is projected to increase in value after the next headline with price going to jump to 357.09. The average volatility of media hype impact on the company stock price is about 52.99%. The price appreciation on the next news is anticipated to be 0.27% where as daily expected return is at this time at 0.26%. The volatility of related hype on Regeneron Pharmaceuticals is about 202.17% with expected price after next announcement by competition of 356.84. The company reported previous year revenue of 7.62 B. Net Income was 2.14 B with profit before overhead, payroll, taxes, and interest of 4.09 B. Given the investment horizon of 30 days, the next projected press release will be in about 8 days.
Additionally take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Regeneron Pharmaceuticals Related Hype Analysis

At Risk
Vertex Pharmaceuticals Incorpor 6.30 8 per month 0.16  0.23  2.80 (1.14)  6.05 
Dr Reddys Laboratories Ltd 0.09 7 per month 0.97  0.0161  2.39 (1.81)  6.20 
Sinovac Biotech Ltd 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Zoetis(1.36) 10 per month 1.57  0.02  1.44 (2.02)  8.38 
Immune Pharmaceuticals 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Perrigo Company Plc 0.60 8 per month 1.51  0.0183  2.79 (1.91)  13.43 
PAREXEL International Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Regeneron Pharmaceuticals 3.51 8 per month 1.51  0.09  2.82 (1.84)  12.69 
SciClone Pharmaceuticals, In 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Origin Agritech Limited 0.06 5 per month 3.49  0.08  9.11 (6.94)  58.70 

Contributor Headline

Latest Prospective on Regeneron Pharmaceuticals

Additionally take a look at Regeneron Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Company logos by clearbit